These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 8828612

  • 1. Long-term follow-up of patients treated for phenylketonuria (PKU). Results from the Prague PKU Center.
    Cechák P, Hejcmanová L, Rupp A.
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S59-63. PubMed ID: 8828612
    [Abstract] [Full Text] [Related]

  • 2. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J, Fromm J, van Teeffelen-Heithoff A, Möller HE, Koletzko B, Marquardt T, Rutsch F, Feldmann R.
    Mol Genet Metab; 2013 Jul; 110 Suppl():S44-8. PubMed ID: 24071437
    [Abstract] [Full Text] [Related]

  • 3. Dynamics of hyperphenylalaninemia and intellectual outcome in teenagers with phenylketonuria.
    Didycz B, Bik-Multanowski M.
    Acta Biochim Pol; 2017 Jul; 64(3):527-531. PubMed ID: 28850634
    [Abstract] [Full Text] [Related]

  • 4. Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria.
    Burgard P, Schmidt E, Rupp A, Schneider W, Bremer HJ.
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S33-8. PubMed ID: 8828606
    [Abstract] [Full Text] [Related]

  • 5. Psychiatric disorders in adult patients with early-treated phenylketonuria.
    Pietz J, Fätkenheuer B, Burgard P, Armbruster M, Esser G, Schmidt H.
    Pediatrics; 1997 Mar; 99(3):345-50. PubMed ID: 9041285
    [Abstract] [Full Text] [Related]

  • 6. Intellectual development and academic achievement of children treated early for phenylketonuria.
    Berry HK, O'Grady DJ, Perlmutter LJ, Bofinger MK.
    Dev Med Child Neurol; 1979 Jun; 21(3):311-20. PubMed ID: 467815
    [Abstract] [Full Text] [Related]

  • 7. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F, Azen C, Guldberg P, Romstad A, Hanley WB, Levy HL, Matalon R, Rouse BM, Trefz F, de la Cruz F, Koch R.
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [Abstract] [Full Text] [Related]

  • 8. Phenylketonuria and its variants: observations on intellectual functioning.
    Netley C, Hanley WB, Rudner HL.
    Can Med Assoc J; 1984 Oct 01; 131(7):751-5. PubMed ID: 6478363
    [Abstract] [Full Text] [Related]

  • 9. Intellectual level (IQ) in heterozygotes for phenylketonuria (PKU). Is the PKU gene also acting by means other than phenylalanine-blood level elevation?
    Thalhammer O, Havelec L, Knoll E, Wehle E.
    Hum Genet; 1977 Oct 14; 38(3):285-8. PubMed ID: 914277
    [Abstract] [Full Text] [Related]

  • 10. Austrian report on longitudinal outcome in phenylketonuria.
    Scheibenreiter S, Tiefenthaler M, Hinteregger V, Strobl W, Mühl A, Ewald A, Schadler M.
    Eur J Pediatr; 1996 Jul 14; 155 Suppl 1():S45-9. PubMed ID: 8828608
    [Abstract] [Full Text] [Related]

  • 11. A longitudinal study of phenylketonuria based on the data of the Budapest Screening Center.
    Schuler A, Somogyi C, Tôrös I, Pataki L, Mété M, Kiss E, Nagy A.
    Eur J Pediatr; 1996 Jul 14; 155 Suppl 1():S50-2. PubMed ID: 8828609
    [Abstract] [Full Text] [Related]

  • 12. [The IQ of heterozygotes for phenylketonuria (PKU). indication of a blood phenylalanine-independent action of the PKU mutant (author's transl)].
    Thalhammer O, Havelec L, Knoll E, Wehle E.
    Wien Klin Wochenschr; 1977 Oct 28; 89(20):684-6. PubMed ID: 930099
    [Abstract] [Full Text] [Related]

  • 13. Long-term follow up of patients with classical phenylketonuria after diet relaxation at 5 years of age. The Paris Study.
    Rey F, Abadie V, Plainguet F, Rey J.
    Eur J Pediatr; 1996 Jul 28; 155 Suppl 1():S39-44. PubMed ID: 8828607
    [Abstract] [Full Text] [Related]

  • 14. Executive functioning in children and adolescents with phenylketonuria.
    VanZutphen K, Packman W, Sporri L, Needham M, Morgan C, Weisiger K, Packman S.
    Clin Genet; 2007 Jul 28; 72(1):13-8. PubMed ID: 17594394
    [Abstract] [Full Text] [Related]

  • 15. Final intelligence in late treated patients with phenylketonuria.
    Trefz FK, Cipcic-Schmidt S, Koch R.
    Eur J Pediatr; 2000 Oct 28; 159 Suppl 2():S145-8. PubMed ID: 11043161
    [Abstract] [Full Text] [Related]

  • 16. Transitory hyperphenylalaninaemia in children with continuously treated phenylketonuria.
    Griffiths P, Smith C, Harvie A.
    Am J Ment Retard; 1997 Jul 28; 102(1):27-36. PubMed ID: 9241405
    [Abstract] [Full Text] [Related]

  • 17. Intelligence in mild atypical phenylketonuria.
    Costello PM, Beasley MG, Tillotson SL, Smith I.
    Eur J Pediatr; 1994 Apr 28; 153(4):260-3. PubMed ID: 8194559
    [Abstract] [Full Text] [Related]

  • 18. Wechsler subscale IQ and subtest profile in early treated phenylketonuria.
    Griffiths PV, Demellweek C, Fay N, Robinson PH, Davidson DC.
    Arch Dis Child; 2000 Mar 28; 82(3):209-15. PubMed ID: 10685922
    [Abstract] [Full Text] [Related]

  • 19. Children and adolescents with phenylketonuria display fluctuations in their blood phenylalanine levels.
    Feldmann R, Schallert M, Nguyen T, Och U, Rutsch F, Weglage J.
    Acta Paediatr; 2019 Mar 28; 108(3):541-543. PubMed ID: 30047169
    [Abstract] [Full Text] [Related]

  • 20. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
    Anastasoaie V, Kurzius L, Forbes P, Waisbren S.
    Mol Genet Metab; 2008 Mar 28; 95(1-2):17-20. PubMed ID: 18703366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.